Table 1 The patients’ characteristics
Age (years) | |
 Median (range) | 63 (27–86) |
Gender | |
 Male | 57 |
 Female | 42 |
Location of primary tumor | |
 Colon | 57 |
 Rectum | 42 |
Histological type | |
 Well, moderately | 78 |
 Poorly, mucinous | 12 |
 Unknown | 9 |
Detection of unresectable tumor | |
 Synchronous | 59 |
 Metachronous | 40 |
The number of organs affected by metastasis | |
 One organ | 54 |
 Multiple organs | 45 |
First-line chemotherapy regimen | |
 FOLFOX | 65 |
 CapeOX | 21 |
 FOLFIRI | 9 |
 SOX | 4 |
Molecular targeted therapy | |
 Bevacizumab | 50 |
 Cetuximab | 15 |
 Panitumumab | 4 |
 None | 30 |
The pretreatment C-reactive protein level | |
 Median (range) | 0.32 (0.02–13.46) |
The pretreatment albumin level | |
 Median (range) | 3.9 (2.4–4.7) |
The pretreatment CRP/ALB ratio | |
 Median (range) | 0.084 (0.004–5.608) |
The pretreatment NLR | |
 Median (range) | 2.788 (0.580–16.306) |
mGPS | |
 0 | 69 |
 1 | 21 |
 2 | 9 |